POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Utah directs state health program to cover hormone replacement therapy for menopause

Original title: Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy

Last action · March 25, 2026: Governor SignedSponsors: Karianne Lisonbee and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Utah directs the Public Employees' Benefit and Insurance Program (PEHP) to include treatments in its for state employees experiencing perimenopausal and menopausal symptoms.

Why it matters

State employees enrolled in PEHP gain insurance coverage for medications designed to relieve perimenopausal and menopausal symptoms.

Background
  • The Public Employees' Benefit and Insurance Program (PEHP) administers health benefits for Utah state and public employees. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Public Employees' Benefit and Insurance Program

PEHP is directed to update its drug formulary to include hormone replacement therapy treatments for perimenopausal and menopausal symptoms.

Directly affected

State employees

State employees enrolled in PEHP gain access to insurance coverage for hormone replacement therapy treatments.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is covered by this resolution?
The resolution directs the Public Employees' Benefit and Insurance Program (PEHP), which serves state employees, to include in its .
What specific treatments are required to be added?
FDA-approved treatments to relieve perimenopausal and menopausal symptoms.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Signed into law.

Procedural history

43 actions
  1. Mar 25, 2026Lieutenant Governor's office for filingEnrolled
    Governor Signed
  2. Mar 17, 2026House
    House/ to Governor
  3. Mar 17, 2026House
    House/ received enrolled bill from Printing
  4. Mar 12, 2026House
    House/ enrolled bill to Printing
  5. Mar 12, 2026Clerk of the House
    Enrolled Bill Returned to House or Senate
  6. Mar 10, 2026Legislative Research and General Counsel / Enrolling
    Draft of Enrolled Bill Prepared
Show 37 earlier actions
  1. Mar 10, 2026Legislative Research and General Counsel / Enrolling
    Bill Received from House for Enrolling
  2. Mar 7, 2026House
    House/ signed by Speaker/ sent for enrolling
  3. Mar 7, 2026House
    House/ received from Senate
  4. Mar 6, 2026Senate
    Senate/ to House
  5. Mar 6, 2026Senate
    Senate/ signed by President/ returned to House
  6. Mar 6, 2026Senate
    Senate/ received from House
  7. Mar 6, 2026House
    House/ to Senate
  8. Mar 6, 2026House
    House/ concurs with Senate amendment
  9. Mar 6, 2026House
    House/ placed on Concurrence Calendar
  10. Mar 6, 2026House
    House/ received from Senate
  11. Mar 6, 2026Senate
    Senate/ to House with amendments
  12. Mar 6, 2026SenateFloor
    Senate/ passed 3rd reading
  13. Mar 6, 2026Senate
    Senate/ 3rd reading
  14. Mar 3, 2026Senate
    Senate/ 2nd reading
  15. Mar 3, 2026Senate
    Senate/ comm rpt/ amended/ placed on Consent Cal
  16. Mar 2, 2026Senate
    Senate Comm - Consent Calendar Recommendation
  17. Mar 2, 2026Senate
    Senate Comm - Favorable Recommendation
  18. Mar 2, 2026Senate
    Senate Comm - Amendment Recommendation
  19. Feb 25, 2026SenateCommittee
    Senate/ to standing committee
  20. Feb 24, 2026SenateIntroduced
    Senate/ 1st reading (Introduced)
  21. Feb 23, 2026Senate
    Senate/ received from House
  22. Feb 23, 2026House
    House/ to Senate
  23. Feb 23, 2026HouseFloor
    House/ passed 3rd reading
  24. Feb 23, 2026House
    House/ 3rd reading
  25. Feb 17, 2026House
    House/ 2nd reading
  26. Feb 17, 2026House
    House/ committee report favorable
  27. Feb 17, 2026House
    House Comm - Favorable Recommendation
  28. Feb 12, 2026HouseCommittee
    House/ to standing committee
  29. Feb 5, 2026House
    House/ received fiscal note from Fiscal Analyst
  30. Feb 5, 2026Released
    LFA/ fiscal note publicly available for HCR010
  31. Feb 5, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HCR010
  32. Feb 4, 2026HouseIntroduced
    House/ 1st reading (Introduced)
  33. Feb 4, 2026House
    House/ received bill from Legislative Research
  34. Feb 4, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HCR010
  35. Feb 4, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HCR010
  36. Feb 4, 2026Legislative Research and General Counsel
    Numbered Bill Publicly Distributed
  37. Feb 4, 2026Legislative Research and General Counsel
    Bill Numbered but not Distributed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

U.S. Food and Drug Administration, U.S. Department of Health and Human Services, Public Employees' Benefit and Insurance Program
OrganizationU.S. Food and Drug Administration“Initiating the removal of broad black box warnings from HRT treatments”Map →
OrganizationU.S. Department of Health and Human Services“Announced FDA removal of warnings from HRT treatments”Map →
OrganizationPublic Employees' Benefit and Insurance Program“State program directed to provide hormone replacement therapy”Map →

Sources

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record